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Peste des Petits Ruminants: state of affairs and the road towards eradication*
Peste des petits ruminants (PPR) is a highly contagious viral disease of small ruminants that causes 
mortality rates that may be as high as 90% in naïve populations. The disease is caused by Peste des petits 
ruminants virus (PPRV), which is an enveloped ribonucleic acid (RNA) virus with a monosegmented genome 
of negative sense, belonging to the genus Morbillivirus in the family Paramyxoviridae. This virus has only 
one seroptype but can be separated in four distinct phylogenetic lineages.
PPR is currently present in Africa, Middle East, and Asia. It represents a serious risk for the economy and 
food security in regions the disease is endemic. With multiple outbreak recorded in Turkey, Georgia and the 
Maghreb region, it is now at the door of Europe. In addition, a recent mass die-off of critically endangered 
Saiga antelopes in Mongolia has been associated with PPR infection, bringing a new light onto the impact 
of this pathogen on wildlife.
Inspired by the eradication of closely related Rinderpest virus, the World Organisation for Animal Health 
(OIE) and the Food and Agriculture Organisation (FAO) launched in 2015 a global campaign for the 
eradication of PPR. This effort will rely on massive vaccination campaigns based on widely-used, live 
attenuated vaccines. The campaign requires an important financial investment, but will clearly be highly 
economically and socially beneficial.
Here, we will review the knowledge of PPR epidemiology and the threat of this disease to Europe. We will 
discuss recent and on-going research of major importance for the success of the eradication campaign, 
notably on vaccine development, transboundary infection dynamics, and the role of wildlife in PPR 
transmission. Finally, we will examine the major gaps in our knowledge of this disease and how those 
could hinder the global eradication effort.
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